article
Background: Rytigynia umbellulate (Hiern) Robyns is often deciduous and has many folklore uses, such as anti-malaria and anti-diabetic. This study investigated the essential oil constituents of Rytigynia umbellulate leaf and stem, along with their antioxidant and cytotoxic activities as well as investigating in-silico molecular docking and ADMET studies of phytoconstituents. Methods: The essential oils were extracted using hydrodistillation and gas chromatography-mass spectrometry (GC-MS) for identification and characterisation. In silico studies were performed using AutoDock Vina in the PyRx workspace. The antioxidant activity of the volatile oils was evaluated using the 2,2ꞌ–diphenyl–1–picrylhydrazyl radical (DPPH*) method, while the brine shrimp lethality test determined cytotoxic potential. Results: The GC-MS analyses revealed eleven and thirteen compounds in the leaves and stem essential oils of R. umbellulata, representing 98.5% and 95.1% of the total oil contents, with phytol (73.5%) and pentadecanal (55.1%) as the most abundant components, respectively. The essential oils showed significant antioxidant activity with a 69.03±0.004 percentage inhibition. The in silico studies supported the cytotoxicity potential of the essential oils with the highest binding affinity and attributed the strongest inhibitory activity to β -Gurjunene and Acorenone with respect to the reference standard, doxorubicin, for both the target proteins. Conclusion: Phytoconstituents of the leaf and stem essential oil of R. umbellulata might be linked to the free radical scavenging and cytotoxic potential observed in this study.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.22541/au.175432886.60918298/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.